Safety Study of Camptothecin-20-O-Propionate Hydrate (CZ48)
Phase 1
- Conditions
- Malignant Lymphoma of Extranodal and/or Solid Organ SiteSolid Tumor
- Interventions
- First Posted Date
- 2015-10-15
- Last Posted Date
- 2019-07-23
- Lead Sponsor
- Cao Pharmaceuticals Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT02575638
- Locations
- 🇺🇸
University of Texas Health Science Center, San Antonio, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath